2012 annual financial data

Supernus Pharmaceuticals 2012 Net margin

Supernus Pharmaceuticals 2012 net margin with verified reported values.

Direct answer

Net margin was -3,127.3%.

Operating income was -42,169,000 USD and net income was -46,284,000 USD.
Operating cash flow was -47,199,000 USD.

Get free Supernus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,480,000 USD
Operating income
-42,169,000 USD
Net income
-46,284,000 USD
Operating cash flow
-47,199,000 USD